Literature DB >> 29261496

[New perspectives on preeclampsia].

Céline Méhats1, Francisco Miralles1, Daniel Vaiman1.   

Abstract

Preeclampsia is a major, frequent and potentially severe condition of pregnancy, characterized by severe hypertension and proteinuria. In this review, we describe recent advances in understanding the pathology, and discuss the long-term impacts on maternal vascular health. Next, we describe the genetic, epigenetic and immunological basis of preeclampsia. We describe the links between preeclampsia and oxidative stress in placental (trophoblast) and endothelial cells. We mention cellular and animal models commonly used to decipher modified pathophysiological pathways in a preeclamptic pregnancy compared to a normal pregnancy. Finally, we discuss the therapeutic options, readily available or in development, to improve the monitoring of pregnancies, the health of patients and that of children born from preeclamptic pregnancies.
© 2017 médecine/sciences – Inserm.

Entities:  

Mesh:

Year:  2017        PMID: 29261496     DOI: 10.1051/medsci/20173312015

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

1.  Nested Case-Control Study of Corin Combined with sFlt-1/PLGF in Predicting the Risk of Preeclampsia.

Authors:  Mei Liu; Rui-Bo Wang; Jian-Hong Xing; Ying-Xue Tang
Journal:  Int J Gen Med       Date:  2021-06-03

2.  Early Preeclampsia Effect on Preterm Newborns Outcome.

Authors:  Melinda Matyas; Monica Hasmasanu; Ciprian N Silaghi; Gabriel Samasca; Iulia Lupan; Kovacs Orsolya; Gabriela Zaharie
Journal:  J Clin Med       Date:  2022-01-17       Impact factor: 4.241

3.  Increased FUN14 domain containing 1 (FUNDC1) ubiquitination level inhibits mitophagy and alleviates the injury in hypoxia-induced trophoblast cells.

Authors:  GuoQing Chen; Lu Chen; Yan Huang; XiongShan Zhu; YuanLan Yu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.